The world mourns the loss of David Nabarro, a renowned British physician and global health leader who played pivotal roles in combating Ebola and COVID-19, remembered as a tireless advocate for health equity.
PEPFAR—the landmark global AIDS relief program started under President Bush—dodged a bullet when it was spared from recent budget cuts that clawed back pledged funds. But don’t breathe easy yet: its long-term funding and stability are still up in the air.
Editor’s Note: PEPFAR has been a lifeline for millions, so avoiding immediate cuts is a relief. But the uncertainty here isn’t just bureaucratic—it’s about whether one of the world’s most effective health programs can keep running at full strength. If funding waffles, so does progress against HIV/AIDS.
A 12-year-old boy from South Carolina, Jaysen Carr, tragically died after being infected by a rare but deadly brain-eating amoeba while swimming in a reservoir. His family's lawyer confirmed the heartbreaking news, marking another rare case of this terrifying infection.
The head of the WHO honored David Nabarro, a physician and global health leader, as a tireless advocate for health equity and pandemic response—most notably during COVID-19. His legacy is one of dedication to public health on a worldwide scale.
The global health community has lost a key leader—Dr. David Nabarro, the British physician who spearheaded the UN’s fight against major outbreaks like Ebola, bird flu, and COVID-19, has passed away. His work shaped how the world responded to some of its deadliest health emergencies.
Michigan stepped up big time on water safety after the Flint disaster, setting new standards and cracking down on contamination. But here’s the catch: mobile home parks are still lagging behind, with many residents stuck dealing with unsafe water. It’s a frustrating gap in an otherwise solid comeback story.
A simple scan called coronary artery calcium testing can spot dangerous plaque buildup in your heart's arteries—giving doctors a clearer picture of your risk for a heart attack. But despite its potential to save lives, this test isn't being used as much as it should be.